Desktop version

Home arrow Health arrow High Density Lipoproteins

A short course of lectures
«High Density Lipoproteins»





ATP-Binding Cassette Transporter A1 (ABCA1)HDL-VHDL InfusionsAcknowledgementRVX-208Autoimmune Diseases: The Role of AutoantibodiesmiRNA-Based TherapyPreservation of Endothelial FunctionApoE and apoA-IV Participate in the Biogenesis of HDL Particles Containing the Corresponding ProteinsHigh-Density Lipoproteins in StrokeCholesterol Efflux as the First Step of Reverse Cholesterol Transport (RCT)High HDL Levels Do Not Add to the ProtectionWeight LossHDL and Bacterial InfectionsSuppression of Monocyte ExtravasationVaccines Against AtherosclerosisLecithin/Cholesterol Acyltransferase (LCAT)HDL SubclassesFuture PerspectivesHDL SubclassesHuman Apo A-I Gene Transfer Influences Metabolic Parameters in Streptozotocin-Induced Diabetes MellitusEpidemiology: Disease AssociationsStructural and Functional Modifications of HDL in CKD PatientsRegulation of HDL Genes: Transcriptional, Posttranscriptional, and PosttranslationalTherapeutic Antisense Oligonucleotides for the Increase of HDL-Cholesterol Levels and Improvement of HDL FunctionHDL and Viral InfectionsDetoxification of Plasma and External FluidsIRI in In Vivo ModelsNiacinPhysiologyEmerging Small Molecule DrugsCarbohydrate and Extrinsic SugarsDietary MUFAHDL Particle NumberFHDL and Reverse Cholesterol TransportNiacinReconstituted HDLs and HDL MimeticsClinical Relevance of the Aberrant HDL PhenotypesHDL and Parasitic InfectionsCholesterol Efflux to Lipidated HDLApoA-I Mutations May Induce Hypertriglyceridemia and/or HypercholesterolemiaHuman Apo A-I Gene Transfer Attenuates Diabetic CardiomyopathyHCV InfectionRole of Ecto-F1-ATPase/P2Y13 Pathway in Hepatic HDL ClearanceHDL ApolipoproteinsCurrent StateApo A-I and Sphingosine-1-Phosphate Mediate the Cytoprotective Effects of HDLNiacinPotential Mechanisms for the Smoking-Related Reduction in HDL-CImpairment of the Endothelial Anti-Apoptotic Effects of HDL in Patients with Cardiovascular DiseaseRemodeling and Catabolism of HDLInteractions of HDLs with the EndotheliumInhibition of LDL Modification by HDLsFFAs and Decreased HDL LevelsImpact of Systemic Inflammation and Autoimmune Diseases on apoA-I and HDL Plasma Levels and FunctionsHepatitis, Dengue and Other VirusesHDL and apoA-I as Members of the Innate Immune SystemIn Vitro Effects of HDL on CardiomyocytesAtherothrombosisEffects of HDLs on Smooth Muscle CellsImpaired HDL Capacity to Stimulate NO Production in Patients with Cardiovascular DiseaseBiogenesis of HDLAre There Other Biomarkers than the Total HDL-C?Suppression of MyelopoiesisHDLs in the Cerebral CompartmentEffects of HDL on ObesityHuman Apo A-I Gene Transfer Attenuates DiabetesAssociated Oxidative Stress, Cardiac Fibrosis,Laboratory Tests to Measure HDL FunctionInteraction of HDL with LPS and Gram-Negative BacteriaMissing HeritabilityHDLs and Acute Stroke: Experimental ModelsPreservation of Endothelial IntegrityEffect of HDL on StrokeBiological MechanismsHigh-Density Lipoprotein: Structural and Functional Changes Under Uremic Conditions and the Therapeutic ConsequencesLoss of Protective Proteins or LipidsSmoking Cessation Intervention to Increase Plasma HDL ConcentrationApoA-I-Induced Cell Signaling Directly Mediated by ABCA1Hepatic Lipase and Endothelial LipaseTherapeutic Potential of HDL in Cardioprotection and Tissue RepairCholesterol Ester Transfer Protein Transgenic MiceApoA-I-Induced Cell Signaling Indirectly Mediated by b-ATPase and P2Y12/13 ADP ReceptorEffects of Substituting Dietary Saturated Fatty Acids“Real” HDL ParticlesATP-Binding Cassette Transporter G1Modulation of Spinghosine-1-Phosphate (S1P)/ S1P-Receptor Axis and Lymphocyte FunctionPON1 as an AntioxidantPhospholipid Transfer ProteinDyslipidemia in CKD PatientsFHDLs, Diabetes, and Metabolic SyndromeCER-001 InfusionsEffects of HDLs on Vascular Lipid and Lipoprotein HomeostasisEffects on HDL Subclass DistributionHDL and DietGeneralRegulation of Genes Involved in HDL Metabolism at the Transcriptional LevelInteraction of HDL with LTA and Gram-Positive BacteriaFibratesTranscytosis of apoA-I and HDL by Endothelial CellsPON1 and OrganophosphatesSignal Transduction by HDL: Agonists, Receptors, and Signaling CascadesHDL Cholesterol as a Risk Factor for Atherosclerosis and Its ComplicationsmiRNAs: Biogenesis and FunctionThe Role of Cubilin in apoA-I and HDL Catabolism by the KidneyI Physiology of HDL PON1 and Bacterial PathogensAlcohol Intake and HDL-CTime Trends in Total HDL-CEffects of Exercise on HDLDysfunctional HDL: From StructureFunction-Relationships to BiomarkersChanges of HDL Apolipoproteins (Modifications and Levels)ABCA1Impact of Adiposity on HDL Concentration and FunctionHDL and Atherothrombotic Vascular DiseaseApoA-I Mimetic PeptidesInflammatory Bowel DiseasesApoA-I MimeticsThe Structure of HDLProtective Role of HDL: Evidence from Epidemiological StudiesStatinsAntisense OligonucleotidesTotal HDL-C in Various PopulationsTranscriptional Regulation of the ABCG1 GeneIII Possible Indications and Target Mechanisms of HDL TherapyMechanisms Under Physiological ConditionsHDL LipidsHDL in the Test TubeLow HDL Cholesterol Levels in Diabetes and Metabolic SyndromeRelationship Between Lipid Raft Modulation and Lymphocyte FunctionSerum Cholesterol Efflux Capacity (CEC)HDL Metabolism, Subclasses, and CatabolismHDL and MycobacteriaEstablished Secondary Regulators of Plasma HDL CholesterolNovel Insight into HDL BiologyFuture PerspectivesFibratesImpact of Anti-inflammatory TreatmentsSelective DelipidationInsights from Intercrossing of the Different Knockout MiceEndothelial Anti-Inflammatory Effects of HDLEffects on Cholesterol Efflux CapacityBiological MechanismsImpairment of the Anti-Oxidative Effects of HDL in Patients After Surgery and With Cardiovascular DiseaseHDL Biogenesis, Remodeling, and CatabolismProteomeParasitesNovel PPAR AgonistsEffects of HDL in Rat Neonatal CardiomyocytesAlterations of the Cholesterol Efflux Capacity of HDL in Cardiovascular DiseaseHDL Confer Protection Against Ischaemia Reperfusion InjuryPharmacologyInterference with Macrophage Differentiation and ActivationStatinsII Pathology of HDLEffects on Plasma HDL-C ConcentrationBacterial PathogensIRI in the Isolated Heart ModelProtective Effects of HDL on the KidneyTranscriptional Regulation of the Human apoM Gene in the LiverHDL-Induced Cell Signaling: Future Challenges and OpportunitiesDeterminants of Plasma HDL Cholesterol LevelsCurrent StateTranscriptional Regulation of the CETP GeneFuture Approaches of Epidemiological StudiesFibratesMyocardial InjuryRheumatoid Arthritis (RA)Functionality of HDL: Antioxidation and Detoxifying EffectsTherapeutic Antisense Oligonucleotides to Treat DyslipidemiaTranscriptional Regulation of the PLTP GeneAdult Mouse CardiomyocytesMouse Models of Disturbed HDL MetabolismHDL ProteomicsMetal Oxides, Carbon Nanotubes and PLGA NanoparticlesMacrophage Cholesterol Efflux and Reverse Cholesterol TransportHigh-Density Lipoproteins, Environmental Pathogens and ToxinsLecithin-Cholesterol AcyltransferasePosttranscriptional Regulation of HDL Genes by Noncoding RNAs and microRNAsNiacinEffect of Weight-Loss Therapies on HDL Concentration and FunctionPosttranslational Mechanisms of HDL Regulationn-3 Polyunsaturated Fatty AcidsPleiotropic Effects of HDLsHDL Quality and Cholesterol EffluxHDL Protein Cargo and Prognostic BiomarkersModified ApoA-ICurrent StateFibratesSystemic Lupus Erythematosus (SLE)Effects of Established Hypolipidemic Drugs on HDL Concentration, Subclass Distribution, and FunctionCSL-111 and CSL-112 InfusionsEffects of Alcohol on HDL Atheroprotective FunctionsPsoriasisMechanisms of ProtectionRCT in Animal ModelsTranscriptional Regulation of the ABCA1 GeneHigh-Density Lipoproteins, Paraoxonase-1Antioxidative StressHigh-Density Lipoproteins: Antioxidative FunctionHDL in Infectious Diseases and SepsisMaking Sense of AntisenseEffects of HDL on Endothelial Nitric Oxide BioavailabilityAnti-inflammatory and Antiprotease PropertiesTranscriptional Regulation of the Apolipoprotein E GeneHDL and Tissue Repair: Modulation of EPC Biology via SR-BIEffect of Antibodies Used for the Treatment of Chronic Inflammatory Diseases on HDL Antiatherogenic FunctionsATP-Binding Cassette Transporter G1Smoking and HDL-C ConcentrationHDLs and Sphingosine 1-PhosphateHDL FractionsThe Origin and Metabolism of Preb-HDL SubpopulationsApproaches to Antibody Therapy for the Increase of HDLCholesterol LevelsScavenger Receptor BIComplexity of HDLPhospholipid Transfer ProteinAntibodiesImpaired Endothelial Anti-Inflammatory Effects of HDL in Patients with CAD, Diabetes, or Chronic Kidney DysfunctionHuman Apo A-I Gene Transfer Reduces Diabetes-Associated Cardiac Apoptosis and Improves the Cardiac Endothelial IntegrityLipidomeAntithrombotic ActionsStatinsEndothelial Cell Integrity, EPCs and Antiapoptotic ActionCholesteryl Ester Transfer Protein InhibitorsIncrease of Molecules within HDL with a Fatal Function in the Vascular WallApo A-I and S1P Confer Cardioprotective Effects on HDLBiological MechanismsHIV InfectionTotal HDL-C Modulated by Environmental FactorsStatinsmiRNAsETC-642Apolipoprotein A-IHDL Potential Effects on the Blood–Brain BarrierPosttranscriptional Modulation of HDL Metabolism by miRNAsapoMHDL and Lifestyle InterventionsFrom LDL Retention to Atheroma FormationFX-5AFibratesMolecular Components of HDLAntisense Oligonucleotides, microRNAs, and AntibodiesPrefaceLipoproteins in the BrainDyslipidemia, Lipid-Modulating Therapy, and Cardiovascular Risk in CKD PatientsMechanisms Under Physiological ConditionsMicromanaging Cholesterol Efflux, RCT, HDL Levels, and HDL FunctionHDL FunctionEffects of HDL on Insulin Sensitivity and Glucose Utilization by Skeletal MuscleChronic Kidney Disease: Epidemiology and PathophysiologyCholesteryl Ester Transfer ProteinABCA1-Mediated Lipid Efflux to Lipid-Poor apoA-IStructure of HDL: Particle Subclasses and Molecular ComponentsEffects of Dietary Fatty Acids and Cholesterol on HDL FunctionAnti-inflammatory EffectsDevelopment of Topical HDL Therapy for Cutaneous Wound HealingInsulin Resistance, Hypertriglyceridemia, and Decreased HDL Cholesterol LevelsGeneral Innate Host Defense Mechanisms Exerted by HDL After Bacterial InfectionSR-BIHigh-Density Lipoproteins and Oxidative StressSmoking CessationPlasma HDLs in the BrainEffects of Alcohol on HDL and Cardiovascular RiskBeyond the Genetics of HDL: Why Is HDL Cholesterol Inversely Related to Cardiovascular Disease?Beneficial Effects of Selective HDL-Raising Gene Transfer on Cardiac Remodelling and Cardiac Function After Myocardial Infarction in MiceAntithrombotic Effects of HDLsScavenger Receptor BINovel LXR AgonistsDoes HDL Play a Causal Role in the Pathogenesis of Diabetes?HDL-C in Diseases and ConditionsDysregulation of Proteins in HDL MetabolismTranscriptional Regulation of the Bile Acid Transporters ABCG5/ABCG8Possibility of Functional Restoration of HDLMechanisms Under Physiological ConditionsHeterogeneity of Antioxidant Activity of HDL ParticlesApoA-Iand HDL-Induced Cell Signaling Indirectly Mediated by ABCA1 and/or ABCG1Effects of Regular Aerobic ExerciseEffect on HDL Antioxidant PropertiesHDL Cholesterol as a Risk Factor for Other DiseasesEffects of HDL on LDL OxidationInflammatory DiseasesTranscriptional Regulation of the HDL Receptor SR-BIVasculitisSources of FundingHDL Particle SizeHuman Apo A-I Gene Transfer Reduces Diabetes-Induced Cardiac Inflammation: Pleiotropic Effects of HDLs—In Vitro and In Vivo DataATI-5261IV Treatments for Dyslipidemias and Dysfunction of HDLDe Novo Synthesis of HDL and HDL BindingHDL-Induced Cell Signaling Mediated by S1PThe Beneficial Effects of HDL in Pancreatic Beta CellsNiacinATP-Binding Cassette Transporter A1Future PerspectivesType 2 Diabetes Mellitus and the Metabolic SyndromeBiological MechanismsTranscriptional Regulation of the apoA-I Gene in the Liver: HDLs and Acute Stroke (In Vivo Data)Effects of HDL on Endothelial Cell Apoptotic PathwaysHDLs and Nitric Oxide (NO)Cholesterol Efflux and Reverse Cholesterol TransportCurrent StateHDL Conversion and RemodelingHDL/apoA-I Structure and FunctionHDL-Induced Cell Signaling Mediated by SR-BIApoA-I-Based Infusion TherapyMechanisms Under Physiological ConditionsPleiotropyABCG1Effects of Exercise on Prevention and Treatment of Cardiometabolic RiskLipid-Modulating Therapy in CKD PatientsStatinsEffect on HDL Ability to Preserve Endothelial Cell HomeostasisMechanisms Under Physiological ConditionsPurified ApoA-I InfusionsLDL-Cholesterol Lowering Approaches: Proprotein Convertase Subtilisin/Kexin Type 9 Blocking AntibodiesEstablished Primary Regulators of Plasma HDL Cholesterol
 
Found a mistake? Please highlight the word and press Shift + Enter